Today's Top Performers In Health Services

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 72 points (-0.5%) at 15,564 as of Friday, Sept. 20, 2013, 12:54 PM ET. The NYSE advances/declines ratio sits at 854 issues advancing vs. 2,087 declining with 92 unchanged.

The Health Services industry currently sits up 0.4% versus the S&P 500, which is down 0.4%. Top gainers within the industry include Agilent Technologies ( A), up 1.8%, Grifols ( GRFS), up 1.3%, Cigna ( CI), up 1.2% and UnitedHealth Group ( UNH), up 0.7%. On the negative front, top decliners within the industry include Insulet Corporation ( PODD), down 5.3%, Catamaran ( CTRX), down 3.5%, Brookdale Senior Living ( BKD), down 2.2% and HCA Holdings ( HCA), down 1.1%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. Techne Corporation ( TECH) is one of the companies pushing the Health Services industry higher today. As of noon trading, Techne Corporation is up $4.18 (5.4%) to $81.90 on heavy volume. Thus far, 224,118 shares of Techne Corporation exchanged hands as compared to its average daily volume of 121,100 shares. The stock has ranged in price between $80.09-$83.83 after having opened the day at $80.33 as compared to the previous trading day's close of $77.72.

Techne Corporation develops, manufactures, and sells biotechnology products and clinical diagnostic controls worldwide. It operates in two segments, Biotechnology and Clinical Controls. Techne Corporation has a market cap of $2.8 billion and is part of the health care sector. Shares are up 12.7% year to date as of the close of trading on Thursday. Currently there is 1 analyst that rates Techne Corporation a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Techne Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Techne Corporation Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Varian Medical Systems ( VAR) is up $0.74 (1.0%) to $76.33 on average volume. Thus far, 486,805 shares of Varian Medical Systems exchanged hands as compared to its average daily volume of 750,100 shares. The stock has ranged in price between $75.58-$76.60 after having opened the day at $75.74 as compared to the previous trading day's close of $75.59.

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software for treating cancer with radiotherapy, radiosurgery, proton therapy, and brachytherapy worldwide. Varian Medical Systems has a market cap of $8.1 billion and is part of the health care sector. Shares are up 6.7% year to date as of the close of trading on Thursday. Currently there are 7 analysts that rate Varian Medical Systems a buy, 1 analyst rates it a sell, and 2 rate it a hold.

TheStreet Ratings rates Varian Medical Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Varian Medical Systems Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Humana ( HUM) is up $1.21 (1.3%) to $95.92 on heavy volume. Thus far, 784,033 shares of Humana exchanged hands as compared to its average daily volume of 1.0 million shares. The stock has ranged in price between $94.90-$96.22 after having opened the day at $95.09 as compared to the previous trading day's close of $94.71.

Humana Inc., a health care company, offers a range of insurance products, and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates in three segments: Retail, Employer Group, and Healthcare Services. Humana has a market cap of $15.6 billion and is part of the health care sector. Shares are up 41.3% year to date as of the close of trading on Thursday. Currently there are 11 analysts that rate Humana a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Humana Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Express Scripts ( ESRX) is up $0.40 (0.7%) to $62.34 on heavy volume. Thus far, 4.2 million shares of Express Scripts exchanged hands as compared to its average daily volume of 3.7 million shares. The stock has ranged in price between $61.96-$62.50 after having opened the day at $62.11 as compared to the previous trading day's close of $61.94.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $53.7 billion and is part of the health care sector. Shares are up 16.5% year to date as of the close of trading on Thursday. Currently there are 12 analysts that rate Express Scripts a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Express Scripts Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Intuitive Surgical ( ISRG) is up $2.65 (0.7%) to $372.63 on heavy volume. Thus far, 573,324 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 631,700 shares. The stock has ranged in price between $368.46-$373.74 after having opened the day at $371.43 as compared to the previous trading day's close of $369.98.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $14.8 billion and is part of the health care sector. Shares are down 23.7% year to date as of the close of trading on Thursday. Currently there are 9 analysts that rate Intuitive Surgical a buy, 3 analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Intuitive Surgical Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Video: Stop Using Student Loan Money to Buy Bitcoin

Video: Stop Using Student Loan Money to Buy Bitcoin

Let the Najarian Brothers Crash-Proof Portfolio

Let the Najarian Brothers Crash-Proof Portfolio

Facebook Sends Facial Recognition Notification in Error

Facebook Sends Facial Recognition Notification in Error

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists